Uncommon Cures, LLC Begins Operations With Series A Funding To Bring Cost-Effective And Time-Efficient Clinical Trials To The Rare Disease Field.
Uncommon Cures, LLC, a privately held rare disease clinical research organization (CRO), begins operations after completing its Series A financing led by PilotRock Investments, LLC. Uncommon Cures brings together a team of rare disease physicians with over 75 years of combined experience and a deeply experienced clinical trials team. Uncommon Cures’ mission is to reduce […]